Gabelli Upgrades Boston Scientific (BSX) to Buy
BSX Hot Sheet
Rating Summary:6 Buy, 13 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 25 | Down: 12 | New: 36
Gabelli upgrades Boston Scientific (NYSE: BSX) from Hold to Buy.
Shares of Boston Scientific are trading higher today amid the Gabelli upgrade and increased earnings estimates at JPMorgan. The stock most recently traded at $10.34, up 3.4% from yesterday's closing price.
To see all the analyst calls on Boston Scientific, visit our Analyst Ratings page.
Boston Scientific Corporation operates as a developer, manufacturer, and marketer of medical devices used in various interventional medical specialties worldwide.
Shares of Boston Scientific are trading higher today amid the Gabelli upgrade and increased earnings estimates at JPMorgan. The stock most recently traded at $10.34, up 3.4% from yesterday's closing price.
To see all the analyst calls on Boston Scientific, visit our Analyst Ratings page.
Boston Scientific Corporation operates as a developer, manufacturer, and marketer of medical devices used in various interventional medical specialties worldwide.
You May Also Be Interested In
- UPDATE: UBS Upgrades Westlake Chemical (WLK) to Neutral; Fairly Valued Now
- Goldman Sachs Upgrades Northrop Grumman (NOC) to Neutral; Coming Back Onto Radar Screens
- Macquarie Upgrades SBA Communications (SBAC) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
